Blog

Gene therapy stocks tank after leading scientist reveals safety … – MarketWatch

Gene therapy stocks tank after leading scientist reveals safety …
MarketWatch
Shares of gene therapy companies fell sharply Tuesday, after a report by a prominent scientist revealed the safety concerns that led him to resign recently from Solid Bioscience Inc.'s SLDB, -17.00% scientific advisory board. Gene therapy researcher

2018-01-30 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.